Digital Health Program for Colorectal Cancer Screening

Recruiting in Palo Alto (17 mi)

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Digital Health Navigation Solutions, Inc

Trial Summary

What is the purpose of this trial?mPATH-CRC (mobile Patient Technology for Health) is an automated direct-to-patient digital health program about colorectal cancer screening. The goal of this project is to test a cloud-based version of mPATH that patients can use at home independent of a scheduled medical visit. Patients will access mPATH on their own devices using a hyperlink sent via text message. The cloud version of mPATH will have the proven effective content of the tablet version, including the ability to request a screening test directly via the program. mPATH will then share this information with the patient's healthcare organization so screening can be arranged. This cloud-based version will be highly scalable, have broad reach, and be easy to support, making it a commercially viable product. This project will (1) test the reach and effectiveness of the mPATH web app in two different healthcare settings: a Fee-for-Service setting, and a value-based care setting; and (2) determine the value generated by mPATH in each healthcare setting.

Eligibility Criteria

This trial is for individuals who are eligible for colorectal cancer screening. Participants will use their own devices to access a cloud-based digital health program, mPATH-CRC, aimed at facilitating the screening process. The specific inclusion and exclusion criteria details were not provided.

Inclusion Criteria

I haven't had recent colorectal cancer screenings as recommended.

I am between 45 and 74 years old.

My cell phone number is listed in my electronic health record.

+2 more

Exclusion Criteria

I have been diagnosed with colorectal cancer before.

I do not have severe liver disease, metastatic cancer, or AIDS.

I have been diagnosed with inflammatory bowel disease.

Participant Groups

The study is testing the effectiveness of mPATH-CRC, a digital health navigation program designed to help patients arrange colorectal cancer screenings from home. It compares this new method with usual care practices in two healthcare settings: Fee-for-Service and value-based care.

2Treatment groups

Experimental Treatment

Placebo Group

Group I: mPATH-CRCExperimental Treatment1 Intervention

Participants randomized to the mPATH arm will receive a text message inviting them to use the mPATH-CRC WebApp. The WebApp verifies individuals are due for routine colorectal cancer (CRC) screening, educates them about their options, and lets them request a screening test via the program.

Group II: Usual Care (Control)Placebo Group1 Intervention

Patients randomized to the control arm will receive usual care, which includes the organizations' standard procedures for addressing CRC screening.